Henan 8204 (8204)

antiasthmatic; Henan 8204 not used in literature; cpd called "8204" was synthesized by Henan Institute of Pharmaceutical Industrial Research; structure given in first source

Also Known As:

8204; 1-(2,3,4-trimethoxybenzyl)-4-(alpha-trimethylsilyloxy-2-(4-amino-3',5'-dichlorophenyl)ethyl)piperazine dihydrochloride; Henan-8204

Networked: 11 relevant articles (0 outcomes, 5 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperazines: 26
    - Henan 8204: 11

Experts

1.	Komann, Marcus: 1 article (04/2019)
2.	Meissner, Winfried: 1 article (04/2019)
3.	Schwenkglenks, Matthias: 1 article (04/2019)
4.	Weinmann, Claudia: 1 article (04/2019)
5.	Ballantyne, Christie M: 1 article (01/2017)
6.	Boerwinkle, Eric: 1 article (01/2017)
7.	Bozkurt, Biykem: 1 article (01/2017)
8.	Butler, Kenneth R: 1 article (01/2017)
9.	Coresh, Josef: 1 article (01/2017)
10.	Hoogeveen, Ron C: 1 article (01/2017)

Related Diseases

1.	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/01/1991 - "From 1982 to 1990, 340 children with newly diagnosed ANLL entered two consecutive AIEOP trials: LAM 8204 (1982-1987) and LAM 87 (1987-1990). " 09/01/1987 - "Treatment of acute myelogenous leukemia in children: results of the Italian Cooperative Study AIEOP/LAM 8204." 01/01/1990 - "Therapy of childhood acute myelogenous leukemia: an update of the AIEOP/LAM 8204 study. " 09/01/1987 - "One hundred thirty-three children with acute myelogenous leukemia (AML) entered the multicenter Pediatric Branch of the Italian Association Against Leukemia trial AIEOP/LAM 8204 between July 1982 and May 1986. "
2.	Stroke (Strokes) 04/01/2010 - "Seasonal variation in the occurrence of stroke in Northern Greece: a 10 year study in 8204 patients." 04/01/2010 - "We recorded the seasonal stroke rates over a 10 year period (from January 1997 to December 2006) in 8204 patients in Northern Greece. " 01/01/2017 - "Methods We evaluated associations between MetS (and groups with similar number of MetS components) and incident heart failure hospitalization, coronary heart disease, stroke and death using hs-cTnT categories after adjusting for risk factors/markers between 1996 and 2011 in 8204 individuals in the Atherosclerosis Risk In Communities study. "
3.	Atherosclerosis 01/01/2017 - "Methods We evaluated associations between MetS (and groups with similar number of MetS components) and incident heart failure hospitalization, coronary heart disease, stroke and death using hs-cTnT categories after adjusting for risk factors/markers between 1996 and 2011 in 8204 individuals in the Atherosclerosis Risk In Communities study. "
4.	Leukemia 09/01/1987 - "One hundred thirty-three children with acute myelogenous leukemia (AML) entered the multicenter Pediatric Branch of the Italian Association Against Leukemia trial AIEOP/LAM 8204 between July 1982 and May 1986. "
5.	Heart Failure 01/01/2017 - "Methods We evaluated associations between MetS (and groups with similar number of MetS components) and incident heart failure hospitalization, coronary heart disease, stroke and death using hs-cTnT categories after adjusting for risk factors/markers between 1996 and 2011 in 8204 individuals in the Atherosclerosis Risk In Communities study. "

Related Drugs and Biologics

1.	lipoarabinomannan (LAM)
2.	antineoplaston A10 (A 10)

Related Therapies and Procedures

1.	Therapeutics
2.	Lithotripsy (Extracorporeal Shockwave Lithotripsy)
3.	Lasers (Laser)